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Background information. Intestinal absorption of alimentary lipids is a complex process ensured by enterocytes
and leading to TRL [TAG (triacylglycerol)-rich lipoprotein] assembly and secretion. The accumulation of circulating
intestine-derived TRL is associated with atherosclerosis, stressing the importance of the control of postprandial
hypertriglyceridaemia. During the postprandial period, TAGs are also transiently stored as CLDs (cytosolic lipid
droplets) in enterocytes. As a ﬁrst step for determining whether CLDs could play a role in the control of enterocyte
TRL secretion, we analysed the protein endowment of CLDs isolated by sucrose-gradient centrifugation from
differentiated Caco-2/TC7 enterocytes, the only human model able to secrete TRL in culture and to store transiently
TAGs as CLDs when supplied with lipids. Cells were analysed after a 24 h incubation with lipid micelles and thus
in a state of CLD-associated TAG mobilization.
Results. Among the 105 proteins identiﬁed in the CLD fraction by LC-MS/MS (liquid chromatography coupled with
tandem MS), 27 were directly involved in lipid metabolism pathways potentially relevant to enterocyte-speciﬁc
functions. The transient feature of CLDs was consistent with the presence of proteins necessary for fatty acid
activation(acyl-CoAsynthetases)andforTAGhydrolysis.IndifferentiatedCaco-2/TC7enterocytes,weidentiﬁedfor
the ﬁrst time LPCAT2 (lysophosphatidylcholine acyltransferase 2), involved in PC (phosphatidylcholine) synthesis,
and 3BHS1 (3-β-hydroxysteroid dehydrogenase 1), involved in steroid metabolism, and conﬁrmed their partial CLD
localization by immunoﬂuorescence. In enterocytes, LPCAT2 may provide an economical source of PC, necessary
formembranesynthesisandlipoproteinassembly,fromthelysoPCpresentintheintestinallumen.Wealsoidentiﬁed
proteins involved in lipoprotein metabolism, such as ApoA-IV (apolipoprotein A-IV), which is speciﬁcally expressed
by enterocytes and has been proposed to play many functions in vivo, including the formation of lipoproteins and
the control of their size. The association of ApoA-IV with CLD was conﬁrmed by confocal and immunoelectron
microscopy and validated in vivo in the jejunum of mice fed with a high-fat diet.
Conclusions. We report for the ﬁrst time the protein endowment of Caco-2/TC7 enterocyte CLDs. Our results
suggest that their formation and mobilization may participate in the control of enterocyte TRL secretion in a
cell-speciﬁc manner.
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Introduction
The intestinal absorption of dietary lipids is a highly
specialized and complex process. In the lumen of the
upper part of the small intestine, TAGs (triacylgly-
cerols), which are the main dietary lipids, are hy-
drolysed by the pancreatic carboxyl ester hydrolase
into fatty acids and 2-monoglycerides that are ab-
sorbed by enterocytes, which resynthesize TAG at
their ER (endoplasmic reticulum) membrane. Newly
synthesized TAGs are in part used for the assembly
of the intestine-speciﬁc TRLs (TAG-rich lipopro-
teins), i.e. chylomicrons, in the secretory compart-
ment. This occurs through the fusion of an ApoB
(apolipoprotein B) molecule stabilized by lipidation
via MTTP (microsomal TAG transfer protein), with
a lipid droplet formed independently in the ER lu-
men.Othersmallexchangeableapolipoproteins,such
as ApoA-IV, associate with chylomicrons (Iqbal and
Hussain,2009).PartofthenewlysynthesizedTAGis
stored as CLDs (cytosolic lipid droplets; Buschmann
and Manke, 1981; Robertson et al., 2003). In entero-
cytes, it has been shown that a dynamic accumula-
tion and depletion of TAG in CLDs occur during
the process of fat absorption (Zhu et al., 2009). In
human differentiated Caco-2 enterocytes, which pro-
duce TRL when supplied with lipid micelles (Chat-
eau et al., 2005; Luchoomun and Hussain, 1999), we
previously demonstrated that TAG stored as CLDs
can be mobilized to contribute to TRL production
(Chateau et al., 2005) and that this TAG partition
can be modulated by nutrients, e.g. glucose (Pauquai
et al., 2006) or polyphenols (Vidal et al., 2005). The
cellular mechanisms responsible for the formation of
CLDs and their mobilization to produce TRL, and
thus the connection between storage and secretion of
TAG, are still poorly understood.
On their surface, CLDs have a protein endowment
thathasbeencharacterizedinvariousmammaliancell
types, including CHO K2 (Chinese-hamster ovary
K2)cells,humansquamousepithelialcarcinomacells
(A431), 3T3-L1 adipocytes, mammary epithelial
cells and hepatic cells (for a review, see Hodges and
Wu, 2010). It includes members of the PLIN (peri-
lipin) family (previously known as PAT family pro-
teins), i.e. the structural proteins of CLDs, as well as
proteins involved in many cellular functions, such as
lipid metabolism, intracellular trafﬁc or signalling.
The proteome of CLDs emerges as variable depend-
ing on the cell type. For example, PLIN-1 is found
speciﬁcally on the adipocyte lipid droplet, PLIN-
5/OXPAT is expressed in cells that have a high capa-
city for fatty acid oxidation, such as cardiac muscle
cells and PLIN-2/ADRP and PLIN-3/TIP47 are ubi-
quitous (for a review, see Wolins et al., 2006). There-
fore it can be hypothesized that the repertoire of pro-
teins associated with CLDs has a functional impact
on the metabolism of a given differentiated cell type.
Todate,PLIN-2/ADRPandPLIN-3/TIP47arethe
only known proteins associated with CLDs in entero-
cytes (Lee et al., 2009). The objective of the present
study was to characterize the proteome of enterocyte
CLDs in order to determine whether intestinal spe-
ciﬁcities exist in these organelles and to gain insights
into their possible role in the balance between TAG
storage and lipoprotein production.
Results
Accumulation of CLDs in mouse jejunum and in
Caco-2/TC7 enterocytes after lipid supply
As a ﬁrst approach, we characterized the localization
of neutral lipids in enterocytes of mouse intestinal
villi as a function of time after olive oil gavage.
Morphological analysis showed that, in control
mice, the jejunum enterocytes were mostly devoid
of CLDs (Figure 1A–1C) and no lipids could be visu-
alized within the Golgi apparatus (Figure 1D). By
contrast, 1 h after olive oil gavage, the cytoplasm of
jejunum enterocytes was full of lipid droplets (Fig-
ures 1E–1H), which were localized at the apical pole
of enterocytes above the nucleus and were larger at
the tip (Figure 1E) than in the lower part of the villi
(Figure 1F). Electron microscopic analysis showed
that the large lipid droplets were not surrounded by
a membrane and were thus cytosolic (Figure 1H).
Despite the huge amount of cytosolic TAG observed
1 h after gavage, none could be visualized 20 h later
(Figure 1I–1K), highlighting the transient nature
of this accumulation. At the same time, the Golgi
apparatus clearly contained lipids, indicating active
lipoprotein secretion (Figure 1L).
We have previously shown that human Caco-
2/TC7 enterocytes, a clone that derives from the
parental Caco-2 cell line, is able to produce TRL
and store TAG as CLDs when supplied with lipid
micelles (Chateau et al., 2005; Vidal et al., 2005).
After a 24 h incubation with lipid micelles, fatty
acid uptake and TAG synthesis are completed,
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Figure 1 Time-dependent distribution of lipid droplets in mouse jejunum after an olive oil gavage
At 4 h after food withdrawal, mice received or not (control) an olive oil bolus (150 μl) by gavage. Control mice were killed 5 h
after food withdrawal (A–D) and mice that received a lipid bolus were killed 1 h (E–H)o r2 0h( I–L) after gavage. Jejunum was
processed for lipid staining by the imidazole-buffered osmium tetroxide method and examined by optical microscopy after
Toluidine Blue staining (A, E, F, I; scale bar, 5 μm) or by electron microscopy (B–D, G, H, J–L; scale bar, 2 μm). CLDs are
indicated by arrows at the optical microscopy level and labelled as CLDs at the electron microscopy level. Red asterisks label
the Golgi apparatus and N indicates the nuclei.
TAG are almost entirely stored as CLDs and, al-
though they are mobilized, the lipoprotein secre-
tion rate is low, as shown in our previous studies
(Chateau et al., 2005; Pauquai et al., 2006). Under
these conditions, confocal microscopy analysis re-
vealedthatthelipiddroplets,visualizedwithBodipy
493/503, were mainly localized at the basal pole of
the cells (see Supplementary Figures S1A and S1B
at http://www.biolcell.org/boc/103/boc1030499add.
htm) and were decorated with PLIN-2 in discrete
patches (Figure 2A and Supplementary Figure S1A).
CLDsappearedasclustersofvarioussizes(Figure2A,
bottom panel), which were larger than and more nu-
merous after the lipid supply as compared with con-
trol conditions (Figure 2A, compare the middle and
top panels). PLIN-2 labelling increased as well in
lipid-loaded cells compared with control cells (Fig-
ure 2A). This was conﬁrmed by quantiﬁcation of the
mean ﬂuorescence of PLIN-2 labelling (Figure 2B)
and by immunoblots of cell lysates probed for PLIN-
2 (Figure 2C). Finally, the increased level of intra-
cellular TAG content in Caco-2/TC7 cells after lipid
supply was conﬁrmed by biochemical quantiﬁcation
(Figure 2D).
Isolation and characterization of the CLDs from
differentiated Caco-2/TC7 enterocytes
Isolation of lipid droplets from the jejunum by
sucrose-gradient centrifugation was unsuccessful,
mainly because the small intestine is a tissue with
a complex architecture, containing many different
cell types, and because the enterocytes of the isolated
epithelial cell layer were very resistant to nitrogen
disruption, the method of choice for cell lysis while
keeping intact the lipid droplets. We thus used dif-
ferentiated Caco-2/TC7 cells for our future studies.
Moreover,sincerinsingthetopfractionleadstoaloss
of lipid droplet-associated proteins, including PLIN-
2, as described by others (Bulankina et al., 2009), we
isolated lipid droplets from Caco-2/TC7 cells by a
single ﬂotation step of the 1000 g cell homogenate
supernatant through a sucrose gradient.
The different fractions recovered from the sucrose
gradient were characterized for lipids and proteins
(Figure 3). To evaluate the degree of enrichment of
TAG, lipid droplet fractionation was performed from
differentiated Caco-2/TC7 cells incubated for 24 h
with lipid micelles supplemented with [1-14C]OA
(oleic acid). Lipids from all gradient fractions as well
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Figure 2 TAG and PLIN-2 content in Caco-2/TC7 cells after incubation with lipid micelles for 24 h
Caco-2/TC7 cells were cultured for 3 weeks on semi-permeable ﬁlters for differentiation and then supplied (+) or not (−;
control conditions) with lipid micelles for 24 h. (A) Cells were stained with Bodipy 493/503 (green) and labelled for PLIN-2 (red;
scale bars, 10 μm). Lower panels show higher magniﬁcations and the insets display magniﬁed areas. Acquisitions were made
from the basal pole of the cells, where most of the lipid droplets are localized (see also Supplementary Figures S1A and S1B).
(B) PLIN-2-associated ﬂuorescence was quantiﬁed from (A) and expressed in arbitrary units.*P<0.05 compared with control
cells. (C) Immunoblotting of PLIN-2 in cell lysates (40 μg of protein) and quantiﬁcation. Results are expressed as percentage of
control. (D) TAG content in cell lysates. Results shown are the means+ −S.E.M. for ﬁve independent experiments performed at
least in duplicate.*P<0.05 when compared with control cells.
as from the homogenate and the supernatant were
extracted and lipid classes were separated by TLC.
As expected, TAG were mainly recovered in frac-
tion 1, the lowest-density fraction, and PL (phos-
pholipids) in fraction 13, which contains cell mem-
branes (Figure 3A). Along with TAG, fraction 1
was also enriched in DGE (diacylglyceryl ether) and
CE (cholesterol ester), both neutral and highly hy-
drophobic lipids, which are thus probably bathed
in the TAG core of the lipid droplets. DGE is a
TAG analogue formed from batyl alcohol, a stable
ether analogue of 2-monoacylglycerol that we use to
evaluate the contribution of the MGAT (monoacyl-
glycerol acyltransferase) pathway to TAG synthesis
(Pauquai et al., 2006). The percentage of [1-14C]OA
incorporated into TAG increased from 53.4+ −3% in
the cell homogenate to 80.2+ −0.6% in the super-
natant loaded on the gradient and to 89.6+ −0.6% in
fraction 1 (Figure 3B; see Supplementary Table S1
at http://www.biolcell.org/boc/103/boc1030499add.
htm). Interestingly, compared with the PL/TAG ra-
tio, the DGE/TAG and the CE/TAG ratios remained
remarkablyconstantinthesesamples,indicatingaco-
enrichment of these hydrophobic lipids with TAG,
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Figure 3 Lipid and protein analysis of sucrose gradient fractions prepared from Caco-2/TC7 cells
Caco-2/TC7 cells were cultured on semi-permeable ﬁlters for 3 weeks for differentiation and then supplied with lipid micelles
for 24 h. For lipid analysis, lipid micelles were supplemented with [1-14C]OA. Cell homogenates were centrifuged for 10 min at
1000 g and the supernatant was fractionated on a sucrose gradient. The top to bottom fractions (1–13) were analysed for lipids
and proteins. (A) Autoradiography of a representative TLC of radiolabelled lipids extracted from cell homogenates, supernatants
and each fraction of the sucrose gradient (FA, fatty acids; DG, diacylglycerol). (B) The radioactive bands from TLC were excised
and the radioactivity was quantiﬁed by scintillation counting to evaluate the incorporation of [1-14C]OA into lipids. Results were
expressed for each fraction as percentage of total [1-14C]OA incorporated into each lipid class. (C) Distribution of PL ()a n dT A G
() in the sucrose gradient fractions. Results are expressed as percentage of total [1-14C]OA incorporated. (D) Immunoblotting
of PLIN-2 (lipid droplet marker), LDH (cytosolic marker), PDI and calnexin (ER markers), GM130 (Golgi matrix protein marker),
HSP60 and prohibitin (mitochondrial markers) and catalase (peroxisome marker). Immunoblotting of ApoB48 was performed to
detect any contamination of the lipid droplet fraction with TRLs. Equal volumes of homogenate and supernatant were loaded on
gels to evaluate the recovery/loss of material after the 1000 g centrifugation step. The same percentage of each fraction of the
sucrose gradient was loaded on gels, except for fractions 1 and 2, which were 2-fold loaded in order to evaluate the presence
of organelle markers with a greater sensitivity.
the major component of the lipid droplet core (Sup-
plementary Table S1). Conversely, the percentage
of [1-14C]OA incorporated into PL decreased from
41.1+ −3.2% in the cell homogenate to 11.4+ −0.8%
in the supernatant and to 1.3+ −0.1% in fraction 1.
Overall, in fraction 1, the [1-14C]OA incorporated
intoneutrallipids(TAG+DGE+CE)accountedfor
more than 98% of the total radioactivity incorpor-
ated and only for less than 2% in PL, as described
earlier (Bartz et al., 2007). Finally, 65.5+ −11.5% of
the TAG and 3.6+ −1% of the PL loaded on the
sucrose gradient were recovered in the top fraction
(Figure 3C). As expected, PLIN-2 was mainly re-
covered in fraction 1 (Figure 3D). Overall, the lowest
density fraction 1 was highly enriched in TAG and
PLIN-2, two markers of lipid droplets.
A set of organelle markers was analysed by West-
ernblottingtoevaluatetherelativepurityoftheisol-
atedCLDs(Figure3D).Thelipid-droplet-containing
fraction was slightly positive for LDH (lactate
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dehydrogenase), an abundant cytosolic enzyme, and
for PDI (protein disulﬁde-isomerase), a luminal ER
protein that has been frequently identiﬁed in CLD
fraction (Hodges and Wu, 2010). Markers of other
compartments,suchascalnexin(ER),GM130(Golgi
matrix 130; Golgi apparatus), HSP60 (heat-shock
protein of 60 kDa) and prohibitin (mitochondria)
and catalase (peroxisomes), were not detected in
fraction 1, although they were easily visualized in
the bottom fractions. Finally, we analysed the frac-
tions for the presence of ApoB48, which is the
non-exchangeable TRL-associated intestinal form of
human ApoB. ApoB48 was not detected in the top
fraction, while it was indeed detected in the
membrane-containing bottom fraction (fraction 13),
indicating that CLDs were not contaminated with
TRL. Overall, although we cannot rule out a slight
contaminationwithcytosolicproteins,ourresultsin-
dicatethatPLIN-2-andTAG-enrichedfraction1was
devoid of other organelles. We thus undertook the
identiﬁcationoftheCLD-associatedproteinsthrough
a proteomic approach.
Identiﬁcation of proteins associated with CLDs
isolated from Caco-2/TC7 cells, by LC-MS/MS
(liquid chromatography coupled with tandem MS)
In initial experiments, proteins were separated by
SDS/10% PAGE and the bands were excised for ana-
lysis by LC-MS/MS after in-gel trypsin digestion.
The proteins that were identiﬁed had the expected
molecular mass, indicating that no proteolysis oc-
curred during the CLD puriﬁcation process. Due to
the high sensitivity and resolution of LC-MS/MS, a
methodthatcanidentifymorethan100proteinsfrom
a gel slice, identiﬁcation of peptides by LC-MS/MS
was performed from unfractionated protein samples
run on a stacking gel and subjected to in-gel trypsin
digestion.Thisproteomicapproachallowedtheiden-
tiﬁcation of 105 proteins (Table 1). The normalized
emPAI (exponentially modiﬁed protein abundance
index) of the identiﬁed proteins ranged from 6.97 to
0.01. The emPAI formula is based on the number of
observedpeptidesnormalizedbythetheoreticalnum-
berofobservablepeptidesperproteinandoffersanes-
timationoftheirrelativeabundancewithinamixture
(Ishihama et al., 2005;Shinoda et al., 2010).In other
words, a 10-fold difference in emPAI between two
proteins indicates an approximately 10-fold differ-
enceintheiramount.Asexpected,themostabundant
protein in CLDs was PLIN-2 (emPAI of 6.97).
The identiﬁed proteins were grouped by function
or localization and were ranked by decreasing emPAI
within a group. Remarkably, 27 proteins (approx.
25% of the total identiﬁed proteins) were directly
involved in lipid metabolism, and only 17 out of the
27 proteins were already reported as associated with
CLDs (Hodges and Wu, 2010). Proteins already re-
portedtobepresentinvariousintracellularorganelles
(ER, mitochondria and lysosomes) were identiﬁed.
Half of them have been identiﬁedin CLD fractions in
a number of previous proteomic studies (for a review,
see Hodges and Wu, 2010): for example, calnexin.
Cytosolic proteins were identiﬁed, and most of them
couldbeclassiﬁedascytoskeletalproteins,chaperones
and enzymes involved in carbohydrate metabolism.
Many of them had already been reported in proteome
studies (Hodges and Wu, 2010). Some of them, such
as tubulin, could indeed be contaminants because of
their high cellular abundance. However, since lipid
droplets are transported through the cell using mi-
crotubules (Spandl et al., 2009), tubulin detection in
the lipid droplet fraction is not surprising.
In the lipid metabolism group, we identiﬁed PLIN
family proteins, fatty acid-activating enzymes, lipo-
lytic enzymes and two enzymes belonging to the
late pathway of cholesterol biosynthesis, i.e. lanos-
terolsynthaseandNSDHL[NAD(P)-dependentster-
oid dehydrogenase-like; Table 1]. Among the PLIN
proteins, PLIN-2/ADRP and PLIN-3/TIP47 were
abundantly represented (emPAI of 6.97 and 3.42
respectively) and no other member of this family
was identiﬁed. Fatty-acid-activating enzymes, which
are necessary to commit fatty acids to a metabolic
process, were identiﬁed and ACSL3 (acyl-CoA syn-
thetase long-chain 3) was the main form associated
with the CLD fraction. Lipolytic enzymes involved
in the hydrolysis of TAG were also present. In partic-
ular, PNPLA2 (patatin-like phospholipase domain
containing 2), also known as ATGL (adipose TAG
lipase), which hydrolyses TAG to diacylglycerol, as
well as its cofactor CGI-58, also known as ABHD5
(α/β-hydrolase domain-containing protein 5), were
recovered in the CLD fraction.
Wedetected11proteinsinvolvedinlipidmetabol-
ism that were not identiﬁed previously in published
CLD proteomes. These proteins are involved in the
PL, sterol or lipoprotein metabolism (Table 1). For
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Table 1 List of identiﬁed (by LC-MS/MS) proteins associated with cytosolic lipid droplets isolated from Caco-2/TC7 cells
Caco-2/TC7 cells were cultured on semi-permeable ﬁlters for 3 weeks for differentiation and then supplied with lipid micelles for 24 h. Cell
homogenates were centrifuged for 10 min at 1000 g and the supernatant was fractionated on a sucrose gradient. The top fraction, containing
the cytosolic lipid droplets, was analysed by LC-MS/MS for protein identiﬁcation. Proteins were identiﬁed with at least two unique peptides. A
Mascot search was performed allowing 1 ‘max. missed cleavage’, 20 p.p.m. ‘peptides mass tolerance’, 0.3 ‘fragment mass tolerance’ and
against Homo sapiens taxonomy (20401 sequences). Mascot search results were ﬁltered by P=0.01 and false discovery rate below 1.6%.
The proteins were identiﬁed in at least two out of three independent experiments. The proteins already reported in mammalian CLD proteome
are indicated (a, reported in the recent review of Hodges and Wu, 2010; b, Moessinger et al., 2011). Proteins are grouped by function or
localization and, inside a group, proteins are ranked by decreasing emPAI.
Entry name Normalized Reported in proteomic
Gene name SwissProt Protein name emPAI studies of lipid droplets
Lipid metabolism
PLIN proteins
PLIN2 PLIN2_HUMAN Perilipin-2, adipose differentiation-related
protein, adipophilin
6.97 a
PLIN3 PLIN3_HUMAN Perilipin-3, mannose-6-phosphate
receptor-binding protein, TIP47
3.42 a
Fatty acid metabolism
ACSL3 ACSL3_HUMAN Long-chain-fatty-acid-CoA ligase 3 2.65 a
ACSL4 ACSL4_HUMAN Long-chain-fatty-acid-CoA ligase 4 0.15 a
Acylglycerol metabolism
MGLL MGLL_HUMAN Monoglyceride lipase 0.67 a
ABHD5 ABHD5_HUMAN 1-Acylglycerol-3-phosphate
O-acyltransferase, abhydrolase
domain-containing protein 5, CGI-58
0.31 a
PNPLA2 PLPL2_HUMAN Patatin-like phospholipase
domain-containing protein 2, adipose
triacylglycerol lipase
0.15 a
Phospholipid metabolism
PCYT1A PCY1A_HUMAN Choline-phosphate cytidylyltransferase A 1.58
LPCAT2 PCAT2_HUMAN Lysophosphatidylcholine acyltransferase 2 0.30 b
Sterol metabolism
HSD17B11 DHB11_HUMAN Oestradiol 17-β-dehydrogenase 11 2.78 a
LSS ERG7_HUMAN Lanosterol synthase 2.46 a
CYB5R3 NB5R3_HUMAN NADH–cytochrome b5 reductase 3 1.63 a
NSDHL NSDHL_HUMAN Sterol-4-α-carboxylate 3-dehydrogenase,
decarboxylating
1.55 a
EPHX1 HYEP_HUMAN Epoxide hydrolase 1 0.31
HSD3B1 3BHS1_HUMAN 3-β-Hydroxysteroid dehydrogenase 0.24
DHRS3 DHRS3_HUMAN Short-chain dehydrogenase/reductase 3 0.13 a
DHCR7 DHCR7_HUMAN 7-Dehydrocholesterol reductase 0.06
HSD17B7 DHB7_HUMAN 3-Oxo-steroid reductase 0.04 a
Lipoprotein metabolism
APOA4 APOA4_HUMAN Apolipoprotein A-IV 6.24
P4HB PDIA1_HUMAN Protein disulﬁde-isomerase 4.71 a
MTTP MTP_HUMAN Microsomal triacylglycerol transfer protein
large subunit
0.53
APOE APOE_HUMAN Apolipoprotein E 0.48
Other lipidic metabolism
FAF2 FAF2_HUMAN FAS-associated factor 2, UBXD8 1.77 a
RDH10 RDH10_HUMAN Retinol dehydrogenase 10 1.24
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Table 1 Continued
Entry name Normalized Reported in proteomic
Gene name SwissProt Protein name emPAI studies of lipid droplets
DHRS1 DHRS1_HUMAN Dehydrogenase/reductase SDR family
member 1
0.56 a
ECHS1 ECHM_HUMAN Enoyl-CoA hydratase, mitochondrial 0.17
SGPL1 SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 0.11
TRAFFIC
RAB7A RAB7A_HUMAN Ras-related protein Rab-7a 2.78 a
RAB1A RAB1A_HUMAN Ras-related protein Rab-1A 1.75 a
RAB5C RAB5C_HUMAN Ras-related protein Rab-5C 1.66 a
RAB10 RAB10_HUMAN Ras-related protein Rab-10 1.15 a
RAB25 RAB25_HUMAN Ras-related protein Rab-25 1.02
RAB11A RB11A_HUMAN Ras-related protein Rab-11A 0.68 a
RAB15 RAB15_HUMAN Ras-related protein Rab-15 0.66
RAB6A RAB6A_HUMAN Ras-related protein Rab-6A 0.20 a
RAB33B RB33B_HUMAN Ras-related protein Rab-33B 0.01 a
ER (endoplasmic reticulum)
ER lumen
HSPA5 GRP78_HUMAN 78 kDa glucose-regulated protein 5.76 a
PDIA3 PDIA3_HUMAN Protein disulﬁde-isomerase A3 3.27 a
CALR CALR_HUMAN Calreticulin 1.97 a
HSP90B ENPL_HUMAN Endoplasmin, heat-shock protein 90 kDa
β member 1, 94 kDa glucose-regulated
protein
1.85 a
PDIA6 PDIA6_HUMAN Protein disulﬁde-isomerase A6 1.52 a
ERO1L ERO1A_HUMAN ERO1-like protein α 0.82 a
PDIA4 PDIA4_HUMAN Protein disulﬁde-isomerase A4 0.81 a
SERPINH SERPH_HUMAN Serpin H1 0.38
ERP44 ERP44_HUMAN Endoplasmic reticulum resident
protein ERp44
0.29
CALU CALU_HUMAN Calumenin 0.28
POR NCPR_HUMAN NADPH–cytochrome P450 reductase 0.27
PLOD2 PLOD2_HUMAN Procollagen-lysine, 2-oxoglutarate
5-dioxygenase 2
0.19
UBXN4 UBXN4_HUMAN UBX domain-containing protein 4, UBX
domain-containing protein 2, Erasin
0.19 a
ERP29 ERP29_HUMAN Endoplasmic reticulum protein ERp29 0.19 a
LRPAP1 AMRP_HUMAN α-2-Macroglobulin receptor-associated
protein, low-density lipoprotein
receptor-related protein-associated
protein 1
0.17
ER membrane, integral protein
CANX CALX_HUMAN Calnexin 0.66 a
AUP1 AUP1_HUMAN Ancient ubiquitous protein 1 0.35 a
RPN1 RPN1_HUMAN Dolichyl-diphospho-oligosaccharide–protein
glycosyltransferase subunit 1
0.34 a
UGT1A6 UD16_HUMAN UDP-glucuronosyltransferase 1-6 0.22
DDOST OST48_HUMAN Dolichyl-diphospho-oligosaccharide–protein
glycosyltranferase 48 kDa subunit
0.18 a
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Table 1 Continued
Entry name Normalized Reported in proteomic
Gene name SwissProt Protein name emPAI studies of lipid droplets
RTN4 RTN4_HUMAN Reticulon-4 0.08
LRRC59 LRC59_HUMAN Leucine-rich repeat-containing protein 59 0.17
Unknown
PRKCSH GLU2B_HUMAN Glucosidase 2 subunit β 0.13
Mitochondria
AIFM2 AIFM2_HUMAN Apoptosis-inducing factor 2,
apoptosis-inducing factor-like
mitochondrion-associated inducer
of death
1.87 a
ATP5B ATPB_HUMAN ATP synthase subunit β, mitochondrial 0.51
HSPA9 GRP75_HUMAN Stress-70 protein, mitochondrial 0.24 a
MDH2 MDHM_HUMAN Malate dehydrogenase, mitochondrial 0.20
HSPD1 CH60_HUMAN 60 kDa heat-shock protein, mitochondrial 0.18 a
Lysosome
PCYOX1 PCYOX_HUMAN Prenylcysteine oxidase 1 0.30
GNS GNS_HUMAN N-Acetylglucosamine-6-sulfatase 0.20
Cytosol
cytoskeleton
TUBB2C TBB2C_HUMAN Tubulin β-2C chain 6.04
TUBB TBB5_HUMAN Tubulin β chain 5.39
TUBB2A TBB2A_HUMAN Tubulin β-2A chain 3.43
ACTB ACTB_HUMAN Actin, cytoplasmic 1 2.70 a
TUBA1B TBA1B_HUMAN Tubulin α-1B chain 2.68
ACTN4 ACTN4_HUMAN α-Actinin-4 1.02
ANXA2 ANXA2_HUMAN Annexin A2 0.86 a
ANXA4 ANXA4_HUMAN Annexin A4 0.35
ELMOD2 ELMD2_HUMAN ELMO domain-containing protein 2 0.34 a
SLC9A3R1 NHRF1_HUMAN Na+/H+ exchange regulatory
cofactor NHERF1
0.27
SEPT2 SEPT2_HUMAN Septin-2 0.17
Carbohydrate metabolism
TPI1 TPIS_HUMAN Triosephosphate isomerase 6.85
PGK1 PGK1_HUMAN Phosphoglycerate kinase 1 1.67
ENO1 ENOA_HUMAN α-Enolase 1.47
ALDOA ALDOA_HUMAN Fructose-bisphosphate aldolase A 1.40
GPI G6PI_HUMAN Glucose-6-phosphate isomerase 1.08
GAPDH G3P_HUMAN Glyceraldehyde-3-phosphate
dehydrogenase
0.76 a
Cytosolic chaperones
HSPA8 HSP7C_HUMAN Heat-shock cognate 71 kDa protein 1.89 a
HSPA1A HSP71_HUMAN Heat-shock 70 kDa protein 1 1.78 a
HSPA6 HSP76_HUMAN Heat-shock 70 kDa protein 6 0.52
HSP90AB1 HS90B_HUMAN Heat-shock protein HSP 90-β 0.20 a
Other function in cytoplasm
CKB KCRB_HUMAN Creatine kinase B-type 5.18
LGALS3 LEG3_HUMAN Galectin-3 1.62
www.biolcell.org | Volume 103 (11) | Pages 499–517 507 © 2011 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.J. Bouchoux and others
Table 1 Continued
Entry name Normalized Reported in proteomic
Gene name SwissProt Protein name emPAI studies of lipid droplets
GSTP1 GSTP1_HUMAN Glutathione transferase P 0.57
GSTA1 GSTA1_HUMAN Glutathione transferase A1 0.44
NDRG1 NDRG1_HUMAN Protein NDRG1 0.26
TRIO TRIO_HUMAN Triple functional domain protein 0.02
Miscellaneous
METTL7B MET7B_HUMAN Methyltransferase-like protein 7B 2.97 a
METTL7A MET7A_HUMAN Methyltransferase-like protein 7A 1.59 a
SCCPDH SCPDH_HUMAN Probable saccharopine dehydrogenase 1.56 a
ATP1B1 P AT1B1_HUMAN Sodium/potassium-transporting ATPase
subunit β-1
0.79
CDH17 CAD17_HUMAN Cadherin-17 0.68
GPA33 GPA33_HUMAN Cell-surface A33 antigen 0.55
C2orf43 CB043_HUMAN UPF0554 protein C2 or f43 0.48 a
GANAB GANAB_HUMAN Neutral α-glucosidase AB 0.26
ATP1A1 AT1A1_HUMAN Sodium/potassium-transporting ATPase
subunit α1
0.11
EEF1A1 EF1A1_HUMAN Elongation factor 1-α10 . 0 9 a
KPNB1 IMB1_HUMAN Importin subunit β-1 0.07
CLIC1 CLIC1_HUMAN Chloride intracellular channel protein 1 0.01
example, PCYT1A [also known as CCT-α (choline-
phosphate cytidylyltransferase A)], the enzyme that
catalyses the rate-limiting step in the choline path-
way for PC (phosphatidylcholine) synthesis (Vance,
2008), and LPCAT2 (lysophosphatidylcholine acyl-
transferase 2), which re-acylates lysophospholipids
by using acyl-CoA, were present in the lipid droplet
fraction.
Proteins involved in the metabolism of lipopro-
tein were also identiﬁed in the CLD fraction of
Caco-2/TC7 enterocytes. MTTP and its subunit,
PDI A1, were detected as well as the exchangeable
ApoA-IV. By contrast, ApoB, the constitutive non-
exchangeable apolipoprotein of TRL, was not iden-
tiﬁed in the proteome. In Caco-2/TC7 cells, after a
24 h incubation with lipid micelles, lipid droplets
are mainly localized at the basal pole of cells, but
some of them are localized in the supranuclear region
(Supplementary Figures S1A and S1B and Chateau
et al., 2005). ApoB is restricted to the apical re-
gion of the cell (Supplementary Figures S1A and
S1B and Morel et al., 2004) and, in this area, as we
showhere,lipiddropletsweresurroundedbyPLIN-2
but devoid of ApoB (Supplementary Figure S1C). As
expected, ApoB colocalized with the ER marker cal-
nexin,and,intheperinuclearregion,Bodipy-labelled
lipid droplets could also be found in close vicinity
of calnexin (Supplementary Figure S1D). However,
ApoB was never detected in these ER-neighbouring
lipid droplets.
LPCAT2 and 3BHS1 (3-β-hydroxysteroid
dehydrogenase 1) expression and localization
in Caco-2/TC7 cells
As mentioned above, some proteins involved in lipid
metabolism were identiﬁed for the ﬁrst time in a
CLD proteome. We analysed the expression and the
localization of LPCAT2, an enzyme involved in the
PC metabolism, and of 3BHS1, an enzyme involved
in the metabolism of steroids, because they were so
far known to localize to the ER membrane (Agarwal
and Garg, 2010; Morimoto et al., 2010; Wang et al.,
2007)andhavenotbeendescribedyetinenterocytes.
Western blot analysis of the sucrose gradient frac-
tions showed that LPCAT2 and 3BHS1 were indeed
mainly associated with the membrane fraction (frac-
tion13).However,bothproteinswerealsodetectedin
the lipid-droplet-containing fraction 1 (Figure 4A).
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Figure 4 Analysis of LPCAT2 and 3BHS1 distribution in
Caco-2/TC7 cells
(A) Western-blot analysis of LPCAT2 and 3BHS1 distribu-
tion along sucrose gradient fractions prepared from differen-
tiated Caco-2/TC7 cells, as described in Figure 3. (B) Con-
focal microscopy analysis of Caco-2/TC7 cells transfected
with LPCAT2myc (red, upper panel) or 3BHS1myc (red, lower
panel) and incubated with 0.6 mM OA. Lipid droplets were
stained with Bodipy (green). Insets show magniﬁed areas of
each panel. Scale bars, 10 μm.
Caco-2/TC7 cells were transfected with plasmids en-
coding myc-tagged LPCAT2 or 3BHS1, and incub-
ated with fatty acids to induce lipid droplet form-
ation. Confocal microscopy analysis clearly showed
that LPCAT2 as well as 3BHS1 localized mainly
around lipid droplets (Figure 4B).
ApoA-IV expression and localization in
Caco-2/TC7 cells and in mouse jejunum
As ApoA-IV is speciﬁcally expressed by entero-
cytes (Green et al., 1980) and strongly up-regulated
by fatty acids (Carriere et al., 2005; Lu et al.,
2002), we further investigated its expression and
localization.
Western blot analysis from differentiated Caco-
2/TC7cellssuppliedwithlipidmicellesfor24 hcon-
ﬁrmed the presence of ApoA-IV in the lipid-droplet-
containing fraction of the gradient (fraction 1, Fig-
ure 5A). Quantiﬁcation indicated that ApoA-IV in
fraction 1 was below 10% of the ApoA-IV loaded on
thesucrosegradient(resultsnotshown).SinceApoA-
IV is a secreted protein, it was expected to be asso-
ciated with the secretory pathway organelles, i.e. ER
and Golgi apparatus (Black, 2007; Gallagher et al.,
2004; Green et al., 1980) and, by immunoﬂuores-
cenceanalysis,ApoA-IVindeedco-localizedpartially
with calnexin, an ER marker (Figure 5B). However,
ApoA-IVwas also detectedonBodipy-labelledCLDs
(Figure5C,emptyarrowheads).Additionally,atriple
labelling showed that some CLDs were positive for
ApoA-IV and PLIN-2 (Figure 5C, empty and white
arrowheads, respectively).
Immunoelectron microscopy analysis of ApoA-IV
was therefore undertaken. As expected, immunogold
labelling was widely distributed (Figure 6A), since
ApoA-IV is present all along the secretory pathway,
whichiswelldevelopedindifferentiatedCaco-2/TC7
cells. Organelles of the secretory compartment (ER
and Golgi apparatus) are located at the apical pole
of the cells (see the ApoB distribution in the three-
dimensional reconstruction on Supplementary Fig-
ure S1). Interestingly, in this area, the edges of CLDs
werelabelledwithclustersofApoA-IV-goldparticles
(Figures6B–6D,arrowheads).Overall,ourresultsin-
dicate that a fraction of ApoA-IV is at the immediate
vicinity of CLDs and remains associated with them
after puriﬁcation by density-gradient ultracentrifu-
gation.
In order to estimate in vivo the relevance of these
results,weanalysedApoA-IVlocalizationinjejunum
of mice fed on a high-fat diet for 2 days, stimu-
lating lipid droplet formation (Figure 7A). As in
Caco-2/TC7 cells, some ApoA-IV labelling could
be detected at the close vicinity of lipid droplets
in jejunum villi (Figures 7B and 7C, empty ar-
rows). Finally, a plasmid encoding human ApoA-
IV was transiently transfected in HeLa cells, which
neither express ApoA-IV endogenously (Figure 8A)
nor secrete TRL. Confocal microscopy showed that,
interestingly, ApoA-IV associates with lipid droplets
and partially co-localized with the dotty-pattern ER-
marker calnexin (Figure 8B) as well as with the lipid
droplet-canonical markers PLIN-2 (Figure 8C) and
PLIN-3 (Figure 8D). Altogether, these data clearly
indicate that ectopic expression of ApoA-IV in HeLa
cells lead to its partial targeting to lipid droplets, as
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Figure 5 Intracellular distribution of ApoA-IV in Caco-2/TC7 cells
Cells were cultured on semi-permeable ﬁlters for 3 weeks and then supplied with lipid micelles for 24 h. (A) Western-blot analysis
of ApoA-IV distribution in sucrose gradient fractions prepared from differentiated Caco-2/TC7 cells as described in Figure 3.
(B) Cells were labelled for ApoA-IV (red) and calnexin (green). Empty arrowheads indicate co-localizations. Nuclei were stained
with DAPI (blue). Scale bar, 10 μm. (C) Cells were labelled for ApoA-IV (red), PLIN-2 (fuchsia), neutral lipids (green) and nuclei
(blue). Scale bar, 5 μm. The boxed area in the merged Figure is shown magniﬁed on the right. White and empty arrowheads
indicate PLIN-2 and ApoA-IV labelling respectively at the surface of lipid droplets.
observed in Caco-2/TC7 enterocytes (Figures 5 and
6) and mouse intestinal cells (Figure 7).
Discussion
We report here the ﬁrst proteome analysis of CLDs
isolated from differentiated Caco-2/TC7 enterocytes.
Observed in enterocytes in vivo (Buschmann and
Manke, 1981) and in cell culture models (Chateau
et al., 2005), lipid droplets have only been recently
suggested as potential players in the physiology of
lipidabsorptioninthegastrointestinaltract(Pauquai
et al., 2006; Zhu et al., 2009). The proteome of dif-
ferentiatedCaco-2/TC7enterocyteCLDs,whichwere
formedafterasupplyofdietarylipids,revealedseveral
characteristics. For example, among the PLIN pro-
tein family, we identiﬁed PLIN-2/ADRP and PLIN-
3/TIP47,butnoPLIN-1,expressedmainlybyadipo-
cytes,orPLIN-5/OXPAT,expressedincellsthathave
a high capacity of fatty acid oxidation. This ﬁnding
is in good agreement with recent data from mouse
intestine (Lee et al., 2009). Approximately 25% of
the proteins identiﬁed in the Caco-2/TC7 enterocyte
CLD fraction were involved in lipid metabolism, and
were mainly linked to the metabolism of TAGs, PLs,
sterols and to the assembly of TRLs (Table 1). In-
terestingly, among these 27 proteins, 11 were newly
identiﬁed proteins associated with CLDs.
TheproteomeincludedproteinsnecessaryforTAG
hydrolysis, supporting a potential dynamic role of
CLDs in the control of TRL production in entero-
cytes. PNPLA2, which hydrolyse TAGs to diacylgly-
cerol, and its co-activator ABHD5 were present in
the proteome. ABHD5/CGI-58 was shown to facil-
itate the mobilization of cytoplasmic TAG and the
assembly and secretion of TRL in McA RH7777 rat
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Figure 6 Immunoelectron microscopy analysis of
ApoA-IV localization in Caco-2/TC7 cells
Cells were cultured on semi-permeable ﬁlters for 3 weeks and
then supplied with lipid micelles for 24 h. After ﬁxation, cells
were embedded in LR White resin and ultrathin sections were
incubated with anti-ApoA-IV antibodies followed by 18 nm
gold particle-labelled secondary antibody. (A) Low magniﬁca-
tion of the apical part of a cell (note the cell microvilli at the top
left corner of the Figure). The lipid droplets appear as elec-
tron-lucent structures. Scale bar, 500 nm. The boxed areas in
(A) are shown enlarged in (B–D). Note that the gold particles
gather in small clusters around the edges of the lipid droplets
(arrowheads).
hepatoma cells and in HepG2 hepatic cells (Brown
et al., 2007; Caviglia et al., 2009) and could play a
similar role in enterocytes. Another hydrolytic en-
zyme, MGLL (monoacylglycerol lipase), was abund-
antlyrepresentedinCaco-2/TC7enterocyteCLDs.Its
function remains obscure, even though it is strongly
increased in intestine of mice upon high fat feed-
ing (Chon et al., 2007). In this study, lipid droplets
were isolated from Caco-2/TC7 cells that had been
incubated for 24 h with lipid micelles, thus in a state
of CLD-associated TAG mobilization (Chateau et al.,
2005). Our proteome results are thus in accordance
with the metabolic state of the Caco-2/TC7 cells.
It is of interest to note that we did not ﬁnd pro-
teins involved in the TAG biosynthetic pathway, al-
though DGAT2 (diacylglycerol acyltransferase 2) has
been previously associated with lipid droplets during
TAG synthesis in ﬁbroblasts and adipocytes (Kuer-
schner et al., 2008). In differentiated Caco-2 cells,
the acyltransferase activities are attributed mainly to
DGAT1, which was not found in our proteome ana-
lysis of lipid droplets. DGAT1 belongs to a protein
family different from that of DGAT2 (Cheng et al.,
2008), but DGAT2 and MGATs belong to the same
protein family. In Caco-2 cells, it is known that the
MGAT pathway, the main TAG synthesis pathway
during lipid absorption in enterocytes, is not very
active (Levy et al., 1995). It would be interesting
to determine whether MGATs can localize to lipid
droplets in enterocytes and whether the localization
of MGLL and MGAT on the lipid droplet surface can
vary depending on the metabolic state of these cells.
The protein repertoire of CLDs included ACSL3
and ACSL4, which are responsible for the activa-
tion of fatty acids prior to their entry into metabolic
pathways, such as de novo lipid synthesis, fatty acid
catabolism or remodelling of membranes. In human
Huh7 hepatocytes, ACSL activity has been involved
in local synthesis of neutral lipids in lipid droplets
(Fujimoto et al., 2007) and, more recently, ACSL3,
whichisthemostabundantACSLinCaco-2/TC7en-
terocytelipiddropletproteome,hasbeenshowntobe
speciﬁcally required for fatty acid incorporation into
PC, an essential reaction for VLDL (very-low-density
lipoprotein) assembly, the hepatic form of TRL (Yao
and Ye, 2008). Although major differences exist, it is
interesting to note that the complex and highly dif-
ferentiated function of TRL assembly and secretion
is shared by hepatocytes and enterocytes.
The proteome included also two enzymes involved
in PC synthesis, the most abundant PL of the mono-
layer surrounding the TAG core of lipid droplets
(Tauchi-Sato et al., 2002). PCYT1A, also known as
CCT-α,catalyzestherate-limitingstepinthecholine
pathway for the synthesis of PC (Vance, 2008). A re-
cent report highlighted the role of PL metabolism in
the formation, utilization, size and number of lipid
droplets (Guo et al., 2008). In Drosophila S2 cells,
CCT1, the orthologue of mammalian CCT-α localiz-
ing in the nucleus, translocates to the lipid droplet
surface upon oleate addition and its knockdown leads
tofewerlipiddropletsoflargersize(Guoet al.,2008).
Moreover, liver-speciﬁc CCT-α-knockout mice dis-
play impaired VLDL secretion in plasma (Jacobs
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Figure 7 Distribution of ApoA-IV in mouse jejunum
Cryostat sections of mouse jejunum were stained for ApoA-IV (red), neutral lipids (green) and nuclei (blue). (A) Low magniﬁcation
showing an entire jejunum villus. Scale bar, 20 μm. (B) Magniﬁed view of the boxed areas in (A). Scale bar, 20 μm. (C) Magniﬁed
view of the boxed areas 1–3 in (B). Empty arrowheads show ApoA-IV labelling at the surface of lipid droplets.
et al., 2004). We also identiﬁed LPCAT2, which re-
acylates lysophospholipids by using acyl-CoA, and
conﬁrmeditslocalizationtolipiddropletsintransfec-
ted Caco-2/TC7 cells. The lipid droplet localization
of LPCAT2 was demonstrated very recently in A431
cells and Cos7 cells (Moessinger et al., 2011). In in-
testine, lysoPC is formed by hydrolysis of the dietary
and biliary PC in the intestinal lumen to be absorbed
by enterocytes. LPCAT2, which remodels PLs inde-
pendently of de novo synthesis (Soupene et al., 2008),
may provide an economical source of PC for mem-
brane synthesis as well as for lipoprotein assembly in
enterocytes (Vance, 2008).
Caco-2/TC7 enterocyte lipid droplets comprise
enzymes involved in sterol and steroid meta-
bolism, including NSDHL, one of the ﬁrst en-
zymes identiﬁed on lipid droplets (Ohashi et al.,
2003) and HSD17B11 (17-β-hydroxysteroid dehyd-
rogenase type 11), which was shown to redistribute
to nascent lipid droplets (Horiguchi et al., 2008).
This enzyme was suggested to be involved in the
metabolism of diet-derived or oxidized hydrophobic,
potentially toxic molecules (Horiguchi et al., 2008).
Such a detoxiﬁcation function would be rather relev-
ant in enterocytes, which are in contact with a large
variety of xenobiotics. We also identiﬁed 3BHS1 and
conﬁrmed its localization to lipid droplets in Caco-
2/TC7 cells. Previous studies described 3BHS1 as
an ER-associated protein (Wang et al., 2007) and
we show for the ﬁrst time its localization to lipid
droplets.
Interestingly, along with MTTP, which is required
for lipoprotein production, we found that ApoA-IV
is associated with the Caco-2/TC7 enterocyte CLD
fraction. MTTP localizes along the secretory path-
way in enterocytes (Levy et al., 2002) and was shown
aroundlipiddropletsindifferentiated3T3-L1adipo-
cytes (Swift et al., 2005). We demonstrated the par-
tial localization of ApoA-IV at the surface of CLDs
by confocal and immunoelectron microscopy. Re-
cently, ApoA-V, another exchangeable apolipopro-
tein that is expressed exclusively in hepatocytes, has
also been found associated with lipid droplets (Shu
et al.,2010).ApoA-IVisstronglyinduceduponlipid
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Figure 8 ApoA-IV subcellular localization in HeLa cells
HeLa cells were transfected (hApoA-IV) or not (mock) and
processed for lysis and immunoﬂuorescence analysis. (A)I m -
munoblottingofApoA-IVandactininmockorhApoA-IVtrans-
fected cells. (B–D) Cells were ﬁxed and labelled with DAPI
(violet), Bodipy (green), anti-ApoA-IV antibody (red) and in-
dicated antibodies (blue): anti-calnexin (B), anti-PLIN-2 (C)
and anti-PLIN-3 (D). Right panels show magniﬁed areas of
each acquisition and arrowheads indicate co-localizations of
ApoA-IV with lipid droplets. Scale bar, 10 μm.
supply (Carriere et al., 2005; Green et al., 1980; Lu
et al., 2002) and has been proposed to play many
functions in vivo, including regulation of food intake,
gastrointestinal motility, lipoprotein formation and
size control, as well as protection against lipid oxida-
tionandatherosclerosis(Black,2007;Luet al.,2002;
Qin and Tso, 2005; Yao et al. 2011). ApoA-IV asso-
ciates with nascent chylomicrons at an early stage
of their biogenesis in the ER and is then secreted
on the surface of mature chylomicrons (Black, 2007;
Gallagher et al., 2004; Green et al., 1980). How can
this protein be associated with both CLDs and lipo-
proteins? The most widely accepted model for CLD
biogenesis proposes that newly synthesized TAG ﬁrst
accumulate between the PL bilayer of the ER mem-
brane to form a lipid droplet, which, after reaching
a critical size, buds towards the cytosolic or the lu-
minal side of the ER membrane (Murphy and Vance,
1999; van Meer, 2001). However, the proposed mod-
els evolved recently to account for the presence on
CLDsofproteinsthatarenormallylocalizedintheER
lumen or at the ER membrane. There are increasing
lines of evidence showing that lipid droplets interact
withvariousorganelles,includingER(Zehmeret al.,
2009). The association of ER-associated proteins and
of ApoA-IV with CLDs could occur through dif-
ferent mechanisms: (i) CLD production by vesicular
budding or by bicelle formation from the ER mem-
brane, leading to the presence of both membrane and
luminal ER proteins (for reviews, see Ohsaki et al.,
2009;WaltherandFarese,2008);(ii)CLDapposition
to particular domains of the ER membrane (Robenek
et al., 2006, 2009).
In conclusion, from our proteome analysis, Caco-
2/TC7 enterocyte CLDs appear as complex organelles
displaying tissue-speciﬁc characteristics. The pres-
ence of proteins necessary for TAG hydrolysis is con-
sistent with the transient feature of lipid droplets
in intestine and Caco-2/TC7 enterocytes. In entero-
cytes, the transient accumulation of CLDs could rep-
resentawaytocontrolTRLsecretionafteralipid-rich
meal.Locatedtolipiddroplets,wealsoidentiﬁedLP-
CAT2, which may provide an economical source of
PC for membrane synthesis as well as for lipopro-
tein assembly in enterocytes. Moreover, the presence
ofApoA-IV,anenterocyte-speciﬁcexchangeableapo-
lipoprotein in the CLD fraction, may suggest a TAG
connection between storage as CLDs and secretion as
TRL. Overall, the CLD protein population may con-
tribute to the control of the postprandial delivery of
TRL by enterocytes. The analysis of the underlying
mechanisms may now be envisaged.
Materials and methods
Antibodies and plasmids
Antibodies
Mouse monoclonal anti-PLIN-2 (AP125, for immunoﬂuores-
cence) and guinea-pig anti-PLIN-3 antibodies were from Pro-
gen.Mousemonoclonalantibodiestocalnexin,PDIandGM130
were from BD Biosciences. Rabbit polyclonal antibodies to
LDH, prohibitin and HSP60 were obtained from Abcam.
Mouse monoclonal antibodies to c-Myc (9E10 clone), LPCAT2
and 3BHS1 were from Sigma. Goat anti-ApoB antibody (for
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immunoﬂurescence) was from Chemicon International and
mousemonoclonalanti-ApoBantibody(1D1,forWesternblots)
was obtained from the Heart Institute of the University of Ott-
awa (Canada). Rabbit anti-ApoA-IV antibody was provided by
M. Zakin (Institut Pasteur, Paris, France) and sheep polyclonal
anti-PLIN-2 (for Western blots) antibody was provided by J.
McLauchlan (Targett-Adams et al., 2003).
Plasmids
For Myc-tagged human LPCAT2 plasmid, residues 141–1775
of the LPCAT2 gene were ampliﬁed by PCR from the IMAGE
clone 3347690 and inserted between the EcoRV and XbaI sites
of the mammalian expression vector pCDNA3.1-myc (Pasde-
loup et al., 2009). GGCGATATCATGAGCCGGTGCGCCC/
ATATCTAGATCAGTCATCTTTTTTGTCTGAGGACTCTC-
TTCATG were used as primers. For myc-HSD3B1 plasmid,
residues 88–1209 of the HSD3B1 gene were ampliﬁed from
IMAGE clone 4755300 and inserted between the EcoRI
and NotI restriction sites of pCDNA3.1-myc. GCTG-
AATTCGATGGCCATGACGGGCTGG/TCAGCGGCCGCT-
CACTGAGTCTTGGACTTCAGGTTCTC were used as
primers. The human ApoA-IV cDNA (hApoA-IV) was kindly
provided by G.S. Shelness (Wake Forest University).
Animals and treatments
Male C57BL/6 mice (6–8 weeks old) were purchased from
Charles River. Mice were maintained in a 12 h light/12 h dark
cycle and fed with a chow diet (AO3, SAFE). All experimental
procedures were in accordance with institutional regulations for
the care and use of laboratory animals. To analyse the distri-
bution of lipid droplets in jejunum as a function of time after
gavage, groups of mice (three mice per group) were fasted for
4 h; then two groups were given a bolus of olive oil (150 μl)
while the third one was kept as a control. At 1 h after the lipid
bolus, which is the time when TAG reaches a peak in plasma
(Hernandez Vallejo et al., 2009), control mice and one group
that received a lipid bolus were killed for jejunum analysis. The
lastgroupwasmaintainedwithoutfoodandkilled20 hafterthe
lipid bolus. In other experiments, mice were fed with a high-fat
diet (24% lard and 3% sunﬂower oil) ad libitum for 2 days. Mice
had free access to water during all procedures.
Cell culture, lipid supply and transfections
Caco-2/TC7 cells were plated at a density of 0.25×106 cells per
small insert (23.1 mm diameter; Becton Dickinson) or 2.6×106
cellsperlargeinsert(75 mmdiameter;Corning)andweregrown
as described previously (Chateau et al., 2005) for differenti-
ation. After 18 days of culture, lipid micelles (2 mM sodium
taurocholate, 0.6 mM OA, 0.2 mM lysoPC, 0.05 mM choles-
terol and 0.2 mM 1-O-octadecyl-rac-glycerol, a stable analogue
of monoacylglycerol) were prepared in a serum-free medium, as
previouslydescribed(Pauquaiet al.,2006),andaddedtotheup-
per compartment for 24 h, a time that allows the determination
of both TRL secretion and CLD accumulation (Chateau et al.,
2005). When appropriate, lipid micelles were supplemented
with 0.1 μCi of [1-14C]OA per ml of ﬁnal medium as described
previously (Chateau et al., 2005).
HeLa cells were grown at 37◦C and 5% CO2 in MEM (min-
imal essential medium) supplemented with antibiotics, glutam-
ine (Invitrogen) and 10% foetal calf serum (AbCys). For plasmid
transfection, Caco-2/TC7 or HeLa cells were seeded on cover-
slips and transfected with 0.5 μg of the indicated plasmid by
lipofection(LipofectamineTM 2000;Invitrogen)accordingtothe
manufacturer’s instructions. To induce lipid droplet production,
0.6 mM OA/BSA was added to the culture medium.
Cells were then processed for microscopy or cell fractiona-
tion, as indicated in the next sections, or rinsed twice with
ice-cold PBS, scraped into lysis buffer (1% Triton X-100 and
5 mM EDTA in PBS) supplemented with a 2% protease inhib-
itor cocktail (P8340; Sigma) and kept frozen until analysis.
Jejunum processing for optical and electron microscopy
Jejunumwasexcised,rinsedin0.1 Mphosphatebuffer(pH 7.4),
cut longitudinally and laid ﬂat in 2.5% glutaraldehyde/0.1 M
cacodylate buffer (pH 7.4). Jejunum were cut into small blocks
and kept for 2 h in this solution for ﬁxation. Blocks were in-
cubated for 1 h in 0.1 M imidazole buffer (pH 7.4) containing
2% osmium tetroxide for neutral lipid staining (Angermuller
and Fahimi, 1982). All material was dehydrated with ethanol
and embedded in Epon 812. Semi-thin sections were stained
for 1 min with Toluidine Blue (1% in 1% sodium tetraborate)
and examined by optical microscopy. Ultrathin sections were
contrast-stained with 3% lead citrate for 1 min and examined
with a Jeol 100 CX-II electron microscope.
Confocal ﬂuorescence microscopy
Jejunum pieces were rinsed, cut longitudinally and laid ﬂat in
4% (w/v) PFA (paraformaldehyde) for 30 min before embedding
in Tissue-Tek. Jejunum cryosections or cells were ﬁxed with 4%
PFA, permeabilized by 0.05% saponin in PBS and incubated
with primary antibodies and then rinsed in PBS. After incuba-
tion with appropriate cyanin dyes or Alexa Fluor®-conjuguated
ﬂuorescent secondary antibodies (Jackson Immunoresearch), tis-
sue sections or cells were stained for neutral lipids by incubation
with Bodipy 493/503 (Invitrogen). After nuclear staining by
DAPI (4 ,6-diamidino-2-phenylindole), samples were examined
by laser scanning confocal microscopy (LSM 510 or LSM 710
microscope; Carl Zeiss). Fluorescence intensity was quantiﬁed
using ImageJ software.
Immunoelectron microscopy
Cells were ﬁxed with 4% PFA in cacodylate buffer for 2 h.
After alcohol-graded dehydration, cells were embedded in LR
White (Electron Microscopy Sciences), and ultrathin sections
were incubated with rabbit anti-human ApoA-IV antibody and
then with 18 nm gold particle-labelled donkey anti-rabbit IgGs
(Jackson Immunoresearch). Sections were analysed in a Jeol
100CX II electron microscope. Images were captured with an
Erlangshen 1000 camera and software (Gatan; Roper Scientiﬁc).
Subcellular fractionation
Lipid droplets were isolated by density-gradient centrifugation
from Caco-2/TC7 cells incubated for 24 h with lipid micelles,
using a protocol adapted from Yu et al. (2000) and Brasaemle
and Wolins (2006). Cell layers (two 75 mm diameter inserts per
centrifuge tube) were rinsed brieﬂy (three times with cold PBS)
and scraped and the volume of the cell homogenate was adjusted
to 2 ml with buffer A (25 mM Tris/HCl, pH 7.4, 100 mM KCl,
1 mM EDTA and 5 mM EGTA) containing a protease inhibitor
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cocktail (Complete® protease inhibitor cocktail from Roche).
Cells were lysed twice using a cell disruption bomb (Parr In-
strument Company; 1200 lbf/in2, 10 min; 1 lbf/in2 =6.9 kPa).
Cellhomogenateswerecentrifugedat1000 gfor10 minat15◦C.
Thelipiddroplet-containingsupernatantwasadjustedto0.33 M
sucrose in a ﬁnal volume of 3 ml, using a 1 M sucrose solution in
buffer A, and transferred into a 12 ml ultracentrifugation tube.
The supernatant was then overlaid sequentially with 3 ml of
0.25 M sucrose-containing buffer A, 3 ml of 0.125 M sucrose-
containing buffer A and 2 ml of 25 mM Tris/HCl (pH 7.4) con-
taining 1 mM EDTA, 1 mM EGTA and the protease inhibitor
cocktail to form a discontinuous sucrose gradient ranging from
0.33 to 0 M. Tubes were centrifuged for 2 h (150000 g,1 5 ◦C) in
a Beckman SW41 rotor and 1 ml fractions were recovered from
the top to the bottom (12 fractions). The pellet (fraction 13)
was rinsed in PBS and suspended in 2 ml of 10 mM Tris/HCl
(pH 7.4) buffer containing 0.25 M sucrose and protease inhibit-
ors. Fractions were stored at −80◦C until use.
Protein concentration and lipid analysis
Protein concentration was determined by the Bio-Rad DC pro-
tein assay with BSA as the standard. Quantiﬁcation of the TAG
content in cell lysates was performed using the PAP150TG kit
(Biomerieux) as described previously (Pauquai et al., 2006). For
the analysis of the lipid classes present in homogenates, su-
pernatants and sucrose gradient fractions, lipids were extracted
withchloroform/methanol(2:1,v/v)andseparatedbyTLCasde-
scribed previously (Chateau et al., 2005). The radioactive bands
wereexcisedandtheradioactivitywasquantiﬁedbyscintillation
counting to evaluate the incorporation of [1-14C]OA into lipids.
Western blotting
Total cell lysates and fractions isolated from sucrose gradient
were fractionated by SDS/10% PAGE (5% for ApoB48) and
proteins were transferred on to a nitrocellulose membrane. After
incubation in TBS-T (20 mM Tris/HCl, pH 7.6, 137 mM NaCl
and 0.1% Tween 20) supplemented with 10% non-fat dried
skimmed milk powder, blots were probed with primary anti-
bodies in TBS-T containing 5% non-fat dried skimmed milk
powder and then with the appropriate peroxidase-conjugated
secondaryantibodies(VectorLaboratories).Blotsweredeveloped
with ECL® reagent (Amersham Pharmacia Biotech). Bands were
visualizedwiththeImageReaderLAS-4000(Fujiﬁlm)andquan-
tiﬁed using ImageJ software.
In-gel trypsin digestion, nanochromatography and MS
analysis
The 1 ml top fractions recovered from the sucrose-density-
gradient ultracentrifugation were freeze-dried, dissolved in
Laemmli buffer and subjected to SDS/PAGE under reducing
conditions. Migration was stopped before the migration front
entered the resolving gel, so that all the proteins of one sample
were still contained in a single band. Gels were silver stained us-
ingaMS-compatiblesilverstainandproteinbandsweredigested
with trypsin as described earlier (Blouin et al., 2010).
PeptideswereseparatedwithanUltimate3000(Dionex)series
HPLC, using a C18 trap column Acclaim pepmap1000 C18
[5 mm particles, 100 A ˚ (1 A ˚ = 0.1 nm) pore, 300 mm i.d.
(inner diameter) and 5 mm length] and an analytical column
C18pepmap100(3 mm,15 cmlength,75 mmi.d.,100 A ˚).Pep-
tides were separated on a gradient of 40 min ranging from 93%
solution A (0.1% triﬂuoroacetic acid)/7% solution B (80% acet-
onitrile and 20% solution A) to 50% solution A/50% solution
B. Eluted fractions were spotted on-line on a MALDI (matrix-
assisted laser-desorption ionization) target using a Probot (Di-
onex) fraction collector. Spotted fractions were mixed 1:4 with
2m g / m lα-CHC (α-cyano-4-hydroxycinnamate; Laser Biolabs)
in 70% acetonitrile containing 0.1% triﬂuoroacetic acid and
Glu-ﬁbrinopeptide at 3 fmol per spot. Fractions were collected
andanalysedusinga4800MALDI-TOF(time-of-ﬂight)analyser
(ABI).
Spectra acquisition and processing were performed using the
4000 series Explorer software (ABI) version 3.5.28193 build
1011 in positive reﬂection mode. External calibration was per-
formed using four calibration points spotted throughout the
plate, additional internal calibration being performed using the
Glu-ﬁbrinopeptide(m/z=1570.677).Foreachfraction,500MS
spectrawereacquiredintherangeof700–4000Da.ForeachMS
spectrum, the eight most abundant peaks were selected for frag-
mentation (1000 MS/MS spectra per precursor). Global MS/MS
peak lists were subjected to an in-house mascot (Matrix Science)
version2.2searchengineforproteinidentiﬁcation(Perkinset al.,
1999). The Swiss Prot 56.8 (410518 sequences; 148080998
residues) release database was used with human as species se-
lection. Parent and fragment mass tolerances were, respectively,
set to 20 p.p.m. and 0.3 Da, partial modiﬁcation (oxidation) of
methionine residues being allowed. A ﬁlter was applied to the
search in order to reduce false positives and matching redund-
ancies of the same peptide in several hits. Peptide score above
20 and FDR (false discovery rate) below 1.6% (P<0.01) were
required. Only proteins identiﬁed with at least two unique pep-
tideswereretained.Whenevertheresultwasambiguous,spectra
were manually checked.
The emPAI offers a label-free, approximate estimation of the
relative abundance of proteins within a mixture (Ishihama et al.,
2005; Shinoda et al., 2010). To compare the emPAI factor across
independent biological experiments, we needed to make it in-
dependent from the amount of sample injected. The normalized
emPAI factor was obtained by calculating ﬁrst the average ratio
of the Mascot emPAI factor of each protein divided by the total
number of proteins identiﬁed in the experiment. This was then
multiplied by the average number of proteins identiﬁed in the
three experiments.
Statistical analysis
Results are presented as means+ −S.E.M. Statistical signiﬁcance
was evaluated using the Student’s t test for unpaired data.
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Figure S1 ApoB does not localize on lipid droplets
Caco-2/TC7 cells were cultured for 3 weeks on semi-permeable ﬁlters for differentiation and then supplied with lipid micelles
for 24 h. (A) Cells were labelled with DAPI (violet) and Bodipy (green), and for perilipin-2 (PLIN-2, blue) and apoB (red). XY plans
from XZ confocal acquisition are shown from top of the cell (apical) every 2 μm. Scale bar=5 μm. (B) Cells were labelled with
DAPI (violet), Bodipy (green) and with anti-apoB antibody (red). XZ confocal acquisition was made and the three-dimensional
image was created using Zen Zeiss software and is shown from apical to basal pole. (C) Cells were labelled with DAPI (violet)
and Bodipy (green), and for apoB (red) and perilipin-2 (PLIN-2, blue). Confocal acquisition was made at the cell perinuclear plan.
Scale bar=5 μm. (D) Cells were labelled with Bodipy (green), and anti-calnexin (blue) and anti-ApoB (red) antibodies. Confocal
acquisition was made at the subapical (left panel) or perinuclear (right panel) plan. Scale bar=10 μm.
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Table S1 Quantiﬁcation of [1-14C]oleic acid incorporated into phospholipids (PL), triacylglycerols (TAG), diacylglyceryl ether
(DGE) and cholesterol esters (CE) of homogenate, supernatant and sucrose gradient fractions 1 and 13
Differentiated Caco-2/TC7 cells were supplied with lipid micelles supplemented with [1-14C]oleic acid for 24 h. Cell homogenates were
centrifuged for 10 min at 1000 g and the supernatant was fractionated on a sucrose gradient to isolate lipid droplets. Lipids were extracted
and fractionated by TLC. Radioactive bands were excised and the radioactivity was counted. Results are expressed, for each fraction, as
a percentage of [1-14C]oleic acid incorporated into each lipid class. Lipid ratios are also indicated. Results shown are means+ −S.E.M.;
n.d., not detectable.
Fraction number
Lipid or ratio Homogenate Supernatant 1 13
PL (%) 41.1+ −3.2 11.4+ −0.8 1.3+ −0.1 85.5+ −3.1
TAG (%) 53.4+ −3.0 80.2+ −0.6 89.6+ −0.6 14.5+ −3.1
DGE (%) 2.6+ −0.1 4.0+ −0.2 4.3+ −0.1 n.d.
CE (%) 2.9+ −0.2 4.4+ −0.3 4.8+ −0.5 n.d.
Total (%) 100 100 100 100
PL/TAG ratio 0.772+ −0.107 0.141+ −0.011 0.014+ −0.001 6.166+ −1.753
DGE/TAG ratio 0.048+ −0.003 0.050+ −0.002 0.047+ −0.001
CE/TAG ratio 0.054+ −0.001 0.056+ −0.004 0.054+ −0.006
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